2.5 semaglutide to tirzepatide The results are in, and the numbers tell a powerful story. The SURMOUNT-5 head-to-head trial put and side by side, revealing a striking difference in outcomes. Tirzepatide delivered an average GLP-1 Appetite Remains High. Dose:2 mg week 7

2.5 semaglutide to tirzepatide The results are in, and the numbers tell a powerful story. The SURMOUNT-5 head-to-head trial put and side by side, revealing a striking difference in outcomes. Tirzepatide delivered an average GLP-1 Appetite Remains High. Dose:2 mg week 7

GLP-1 Appetite Remains High. But For How Long?

PKF275-055, an analog of vildagliptin, is a novel, selective, orally bioavailable, and long-acting DPP-4 inhibitor that has shown promising benefits in the prevention, protection, and treatment of diabetic neuropathy

week 7

Dose:2 mg

Parts of this work were presented at the 81st Scientific Sessions of the American Diabetes Association, virtual meeting, 25–29 June 2021